enable : true
heading : Our
headingSpan : Team
teamMember :
  - image : images/team/Jianxin_Bao.JPG
    name : Jianxin Bao, Ph.D.
    designation : CEO/Founder
    description : Dr. Bao received his Ph.D. in neuroscience from the University of Florida and obtained postdoctoral research training at Stanford University, Harvard University and Columbia University. His first faculty position was at Columbia University and he later became a tenured faculty at Washington University in St. Louis. Within his 17 years of research experience in the field of hearing disorders, Dr. Baoâ€™s research excellence has been recognized by multiple awards from National Institute on Aging and the National Institute on Deafness and Other Communication Disorders (NIDCD). His interactions with clinicians and researchers at both academic and industrial institutions has allowed Dr. Bao to direct the focus of Gateway Biotechnology Inc. to potential treatments for hearing disorders. Based on his research efforts at Washington University in St Louis, two drug candidates have been identified for use against noise-induced hearing loss, and now these two drugs have been approved by FDA for clinical trials to prevent noise-induced hearing loss (NCT02049073). 
    socialIcon :
      - icon : tf-ion-social-facebook
        url : "#"
      - icon : tf-ion-social-twitter
        url : "#"
      - icon : tf-ion-social-linkedin
        url : "#"
      - icon : tf-ion-social-dribbble-outline
        url : "#"
      
  - image : images/team/Richard_Chole.jpg
    name : Richard Chole, M.D., Ph.D
    designation : Co-founder
    description : Dr. Chole is a well-known clinician with a specialty in neurotology, and he has also led multiple funded research projects in the Department of Otolaryngology at Washington University in St. Louis. Dr. Chole carried out the first study of age-related hearing loss in the C56BL/6J strain of mice. He has experience in clinical studies and has conducted several randomized clinical trials in the field of hearing disorders. Dr. Chole's clinical interests include otology, neurotology, reconstruction of the middle ear, petrous apicitis, otosclerosis, cholesteatoma, Meniere's disease, cochlear implants and bone-anchored hearing aids.
    socialIcon :
      - icon : tf-ion-social-facebook
        url : "#"
      - icon : tf-ion-social-twitter
        url : "#"
      - icon : tf-ion-social-linkedin
        url : "#"
      - icon : tf-ion-social-dribbble-outline
        url : "#"
      
  - image : images/team/Philip_Perez.jpg
    name : Philip Perez, M.D.
    designation : CMO/Co-founder
    description : Dr. Perez received his undergraduate education at Harvard University, and his medical school education at Washington University in St. Louis. He has been involved in the first drug repurposing studies against hearing loss at Washington University in St. Louis. He is now practicing at the Department of Otolaryngology-Head and Neck Surgery at the University of California in San Francisco.  
    socialIcon :
      - icon : tf-ion-social-facebook
        url : "#"
      - icon : tf-ion-social-twitter
        url : "#"
      - icon : tf-ion-social-linkedin
        url : "#"
      - icon : tf-ion-social-dribbble-outline
        url : "#"
  